Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-12-002297
Filing Date
2012-07-27
Accepted
2012-07-27 15:52:37
Documents
5
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT admp-10ka_033112.htm 10-K/A 433467
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 15374
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 18166
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 7878
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-32_2.htm EX-32.2 8026
  Complete submission text file 0001387131-12-002297.txt   484047
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 000-26372 | Film No.: 12990650
SIC: 2834 Pharmaceutical Preparations